Related Experiment Video
Updated: Jul 7, 2026
08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
[New technologies in lung cancer radiotherapy]
G Noël1, C Schumacher, C Niederst
1Centre de lutte contre le cancer Paul-Strauss, BP 42, 3 rue de la Porte de l'Hôpital, 67065 Strasbourg cedex, France. gnoel@strasbourg.fnclcc.fr
Revue Des Maladies Respiratoires
|February 22, 2008
Summary
Lung cancer radiotherapy has significantly advanced over the past decade due to technological innovations in imaging and software. These improvements have transformed all stages of lung cancer treatment, enhancing precision and patient care.
Area of Science:
- Medical Physics
- Oncology
- Radiotherapy Technology
Background:
- Lung cancer radiotherapy has undergone significant evolution in the last decade.
- Technological advancements in imaging, software, and hardware have been key drivers of this progress.
Purpose of the Study:
- To review the advancements in lung cancer radiotherapy over the past ten years.
- To highlight the impact of new technologies on radiotherapy procedures and clinical practice.
Main Methods:
- Review of technological improvements in all phases of lung cancer radiotherapy.
- Analysis of changes in immobilization, imaging, target delineation, simulation, dose calculation, and treatment verification.
- Discussion of the impact of new technologies on the mindset of physicians and physicists.
Main Results:
- Radiotherapy procedures for lung cancer have been drastically transformed.
- Improvements span immobilization, 3D imaging, target and organ delineation, simulation, dose calculation, daily setup, breathing control, and verification.
- New technologies necessitate technical adjustments and a shift in professional perspectives.
Conclusions:
- Technological progress has substantially improved lung cancer radiotherapy.
- The integration of advanced technologies requires adaptation from healthcare professionals.
- Continued innovation promises further enhancements in lung cancer treatment efficacy and safety.
